Ascentage Pharma, a titan in the biopharmaceutical landscape, has recently unveiled groundbreaking data revolving around the MDM2 gene. As an influential player in cancer’s insidious progression, MDM2 has long been regarded as a target of immense therapeutic significance. This latest breakthrough from Ascentage, a company known for its relentless pursuit of solutions for unmet medical […]